Towards clinical implementation of circulating cell-free DNA in precision medicine

References

[1] Siegel RL,Jemal A.Cancer statistics, 2018..CA Cancer J Clin2018;68:7-30

[2] Chen W,Baade PD,Zeng H.Cancer statistics in China, 2015..CA Cancer J Clin2016;66:115-32

[3] Siravegna G,Siena S.Integrating liquid biopsies into the management of cancer..Nat Rev Clin Oncol2017;14:531-48

[4] Wan JC,Garcia-Corbacho J,Brenton JD.Liquid biopsies come of age: towards implementation of circulating tumour DNA..Nat Rev Cancer2017;17:223-38

[5] Li W,Lu X,Song Y.5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers..Cell Res2017;27:1243-57 PMCID:PMC5630683

[6] Xu RH,Krawczyk M,Luo H.Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma..Nat Mater2017;16:1155-61

[7] Zeng C,Zhang Z,Zhang W.Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy..Cancer Commun (Lond)2019;39:12 PMCID:PMC6440138

[8] Cai J,Zhang Z,Lu X.Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma..Gut2019;[Epub ahead of print]

[9] Song CX,Ma L,Chen Y.5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages..Cell Res2017;27:1231-42 PMCID:PMC5630676

[10] Jahr S,Englisch S,Fackelmayer FO.DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells..Cancer Res2001;61:1659-65

[11] Han D,Shih AH,You Q.A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell Populations..Mol Cell2016;63:711-9 PMCID:PMC4992443

[12] Song CX,Fu Y,Yi C.Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine..Nat Biotechnol2011;29:68-72 PMCID:PMC3107705

[13] Shen SY,Fehringer G,Roehrl MHA.Sensitive tumour detection and classification using plasma cell-free DNA methylomes..Nature2018;563:579-83

[14] Gyanchandani R,Heller R,Smith N.Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood..Sci Rep2018;8:17313 PMCID:PMC6251935

[15] Zhang Z.Fragmentation patterns of circulating cell-free DNA demonstrate biomarker potential for human cancers..Biotarget2019;3:pii:16 PMCID:PMC6714582

[16] Cristiano S,Phallen J,Adleff V.Genome-wide cell-free DNA fragmentation in patients with cancer..Nature2019;570:385-9

[17] Jiang P,Tong YK,Cheng THT.Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma..Proc Natl Acad Sci U S A2018;115:E10925-33 PMCID:PMC6243268

[18] Yang Y,Lu X,Nie J.5-Hydroxymethylcytosines in circulating cell-free DNA reveal vascular complications of type 2 diabetes..Clin Chem. Forthcoming2019;